Tanoto Foundation made a generous pledge to support cell therapy discovery led by Katy Rezvani – MD Anderson Cancer Center
Katy Rezvani shared a post by MD Anderson Cancer Center, on X, adding:
“Deeply grateful to the Tanoto Foundation for their generous pledge. Their support will propel our team’s cell therapy research forward, bringing us closer to innovative treatments and improved outcomes for our patients with AML Thank you for believing in our work!”
Quoting MD Anderson Cancer Center‘s post:
“Recently, the Tanoto Foundation made a generous pledge to support cell therapy discovery and innovation research, led by our Dr. Katy Rezvani and her team. Read more.”
Source: Katy Rezvani/X and MD Anderson Cancer Center/X
Katy Rezvani, holds roles including Professor of Medicine, Director of Translational Research, and Chief of the Section of Cellular Therapy at MD Anderson Cancer Center. Previously, she directed stem cell transplant programs and research laboratories at Hammersmith Hospital, London. Dr. Rezvani’s research focuses on enhancing natural killer (NK) cell function against leukemia, utilizing genetic engineering techniques. Her work has led to funded Phase I/II trials in leukemia and lymphoma immunotherapy.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023